Sangrado gastrointestinal en pacientes hospitalizados

Autores:: Diaztagle F., Juan José
Cruz B., Roberto H.
Eslava O., David F.
Briceño P., Juan F.
Hernández A., Andrés C.
Jiménez M., Natalia
Jiménez M., Mónica
Melo F., Laura C.
Sierra M., Ronald E.
Vásquez H., Leonidas

Tipo de recurso:: Article of journal

Fecha de publicación:: 2014

Institución:: Fundación Universitaria de Ciencias de la Salud - FUCS

Repositorio:: Repositorio Digital Institucional ReDi

Idioma:: spa

id	FUCS2_b92c3611b3277ab29d723297e09f627a
oai_identifier_str	oai:repositorio.fucsalud.edu.co:001/2760
network_acronym_str	FUCS2
network_name_str	Repositorio Digital Institucional ReDi
repository_id_str
dc.title.spa.fl_str_mv	Sangrado gastrointestinal en pacientes hospitalizados
dc.title.translated.eng.fl_str_mv	Gastrointestinal bleeding in hospitalized patients
title	Sangrado gastrointestinal en pacientes hospitalizados
spellingShingle	Sangrado gastrointestinal en pacientes hospitalizados úlceras de estrés profilaxis sangrado gastrointestinal terapia de supresión ácida inhibidores de bomba de protones antagonistas de receptores de histamina tipo 2 Stress ulcers prophylaxis gastrointestinal bleeding acid suppression therapy proton pump inhibitors histamine 2 receptor antagonists
title_short	Sangrado gastrointestinal en pacientes hospitalizados
title_full	Sangrado gastrointestinal en pacientes hospitalizados
title_fullStr	Sangrado gastrointestinal en pacientes hospitalizados
title_full_unstemmed	Sangrado gastrointestinal en pacientes hospitalizados
title_sort	Sangrado gastrointestinal en pacientes hospitalizados
dc.creator.fl_str_mv	Diaztagle F., Juan José Cruz B., Roberto H. Eslava O., David F. Briceño P., Juan F. Hernández A., Andrés C. Jiménez M., Natalia Jiménez M., Mónica Melo F., Laura C. Sierra M., Ronald E. Vásquez H., Leonidas
dc.contributor.author.spa.fl_str_mv	Diaztagle F., Juan José Cruz B., Roberto H. Eslava O., David F. Briceño P., Juan F. Hernández A., Andrés C. Jiménez M., Natalia Jiménez M., Mónica Melo F., Laura C. Sierra M., Ronald E. Vásquez H., Leonidas
dc.subject.spa.fl_str_mv	úlceras de estrés profilaxis sangrado gastrointestinal terapia de supresión ácida inhibidores de bomba de protones antagonistas de receptores de histamina tipo 2
topic	úlceras de estrés profilaxis sangrado gastrointestinal terapia de supresión ácida inhibidores de bomba de protones antagonistas de receptores de histamina tipo 2 Stress ulcers prophylaxis gastrointestinal bleeding acid suppression therapy proton pump inhibitors histamine 2 receptor antagonists
dc.subject.eng.fl_str_mv	Stress ulcers prophylaxis gastrointestinal bleeding acid suppression therapy proton pump inhibitors histamine 2 receptor antagonists
publishDate	2014
dc.date.accessioned.none.fl_str_mv	2014-03-01 00:00:00 2022-06-29T19:36:12Z
dc.date.issued.none.fl_str_mv	2014-03-01
dc.date.available.none.fl_str_mv	2014-03-01 00:00:00 2022-06-29T19:36:12Z
dc.type.spa.fl_str_mv	Artículo de revista
dc.type.eng.fl_str_mv	Journal article
dc.type.coar.fl_str_mv	http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.coar.spa.fl_str_mv	http://purl.org/coar/resource_type/c_6501 http://purl.org/coar/resource_type/c_dcae04bc
dc.type.driver.spa.fl_str_mv	info:eu-repo/semantics/article
dc.type.version.spa.fl_str_mv	info:eu-repo/semantics/publishedVersion
dc.type.content.spa.fl_str_mv	Text
dc.type.redcol.spa.fl_str_mv	http://purl.org/redcol/resource_type/ARTREV
dc.type.coarversion.spa.fl_str_mv	http://purl.org/coar/version/c_970fb48d4fbd8a85
format	http://purl.org/coar/resource_type/c_6501
status_str	publishedVersion
dc.identifier.doi.none.fl_str_mv	10.31260/RepertMedCir.v23.n1.2014.736
dc.identifier.issn.none.fl_str_mv	0121-7372
dc.identifier.uri.none.fl_str_mv	https://repositorio.fucsalud.edu.co/handle/001/2760
dc.identifier.eissn.none.fl_str_mv	2462-991X
dc.identifier.url.none.fl_str_mv	https://doi.org/10.31260/RepertMedCir.v23.n1.2014.736
identifier_str_mv	10.31260/RepertMedCir.v23.n1.2014.736 0121-7372 2462-991X
url	https://repositorio.fucsalud.edu.co/handle/001/2760 https://doi.org/10.31260/RepertMedCir.v23.n1.2014.736
dc.language.iso.spa.fl_str_mv	spa
language	spa
dc.relation.references.spa.fl_str_mv	Marik P, Vasu T, Hirani A, Pachinburavan M. Stress ulcer prophylaxis in the new millenium: A systematic review and meta-analysis. Crit Care Med. 2010; 38:2222-28. Grube RR, May DB. Stress ulcer prophylaxis in hospitalized patients not in intensive care units. Am J Health Syst Pharm. 2007 Jul 1; 64(13):1396-400. Fennerty MB. Pathophysiology of the upper gastrointestinal tract in the critically ill patient: rationale for the therapeutic benefits of acid suppression. Crit Care Med. 2002 Jun; 30(6 Suppl):S351-5. Mutlu GM, Mutlu EA, Factor P. GI complications in patients receiving mechanical ventilation. Chest. 2001;119(4):1222-41. Metz DC. Preventing the gastrointestinal consequences of stress-related mucosal disease. Curr Med Res Opin. 2005 Jan; 21(1):11-8. Quenot JP, Thiery N, Barbar S. When should stress ulcer prophylaxis be used in the ICU?. Curr Opin Crit Care. 2009; 15:139-43. Amaral MC, Favas C, Alves JD, Riso N, Riscado MV. Stress-related mucosal disease: Incidence of bleeding and the role of omeprazole in its prophylaxis. Eur J Int Med. 2010; 21(5):386-88. Qadeer MA, Richter JE, Brotman DJ. Hospital-acquired gastrointestinal bleeding outside the critical care unit: risk factors, role of acid suppression, and endoscopy findings. J Hosp Med. 2006 Jan; 1(1):13-20. Herzig SJ, Vaughn BP, Howell MD, Ngo LH, Marcantonio ER. Acid-suppressive medication use and the risk for nosocomial gastrointestinal tract bleeding. Arch Intern Med. 2011 Jun 13; 171(11):991-7. Cook DJ, Fuller HD, Guyatt GH, Marshall JC, Leasa D, Hall R, et al. Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group. N Engl J Med. 1994 Feb 10; 330(6):377-81. Cook D, Heyland D, Griffith L, Cook R, Marshall J, Pagliarello J. Risk factors for clinically important upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group. Crit Care Med. 1999 Dec; 27(12):2812-7. Steinberg KP. Stress-related mucosal disease in the critically ill patient: risk factors and strategies to prevent stress-related bleeding in the intensive care unit. Crit Care Med. 2002 Jun; 30 (6 Suppl):S362-4. Stollman N, Metz DC. Pathophysiology and prophylaxis of stress ulcer in intensive care unit patients. J Crit Care. 2005 Mar; 20(1):35-45. Martindale RG. Contemporary strategies for the prevention of stress-related mucosal bleeding. Am J Health Syst Pharm. 2005 May 15; 62(10 Suppl 2):S11-7. Terdiman JP, Ostroff JW. Gastrointestinal bleeding in the hospitalized patient: a case-control study to assess risk factors, causes, and outcome. Am J Med. 1998 Apr; 104(4):349-54. Estruch R, Pedrol E, Castells A, Masanes F, Marrades RM, Urbano-Marquez A. Prophylaxis of gastrointestinal tract bleeding with magaldrate in patients admitted to a general hospital ward. Scand J Gastroenterol. 1991 Aug; 26(8):819-26. Grau JM, Casademont J, Fernandez-Sola J, Cardellach F, Urbano-Marquez A. Prophylaxis of gastrointestinal tract bleeding in patients admitted to a general hospital ward. Comparative study of sucralfate and cimetidine. Scand J Gastroenterol. 1993 Mar; 28(3):244-8. ASHP Therapeutic Guidelines on Stress Ulcer Prophylaxis. ASHP Commission on Therapeutics and approved by the ASHP Board of Directors on November 14, 1998. Am J Health Syst Pharm. 1999 Feb 15; 56(4):347-79. Cook D, Guyatt G, Marshall J, Leasa D, Fuller H, Hall R, et al. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. N Engl J Med. 1998 Mar 19; 338(12):791-7. Conrad SA, Gabrielli A, Margolis B, Quartin A, Hata JS, Frank WO, et al. Randomized, double blind comparison of immediate-release omeprazole-oral suspension versus intravenous cimetidina for prevention of upper gastrointestinal bleeding in critically ill patients. Crit Care Med. 2005; 33(4):760-65. Cook DJ, Witt LG, Cook RJ, Guyatt GH. Stress ulcer prophylaxis in the critically ill. A meta-analysis. Am J Med. 1991 Nov; 91(5):519-27. Tryba M. Prophylaxis of stress ulcer bleeding. A meta-analysis. J Clin Gastroenterol. 1991; 13 Suppl 2:S44-55. Cook DJ, Reeve BK, Guyatt GH, Heyland DK, Griffith LE, Buckingham L, et al. Stress ulcer prophylaxis in critically ill patients. Resolving discordant metaanalyses. JAMA 1996; 275 (4): 308-14. Lin P, Chang Ch, Hsu P, Tseng P, Huang Y. The efficacy and safety of protom pump inhibitors vs histamine-2 receptor antagonist for stress ulcer bleeding prophylaxis among critical care patients: A metanalysis. Crit Care Med. 2010: 38(4): 1197-1205. Pham CQ, Regal RE, Bostwick TR, Knauf KS. Acid suppressive therapy use on an inpatient internal medicine service. Ann Pharmacother. 2006 Jul-Aug; 40(7-8):1261-6. Nardino RJ, Vender RJ, Herbert PN. Overuse of acid-suppressive therapy in hospitalized patients. Am J Gastroenterol. 2000 Nov; 95(11):3118-22. Noguerado Asensio A, Rodriguez Barrientos R, Zelaya Castro P, Sanchez Sempere A, Antuna Blanco F, Lutz Garcia E, et al. [Use of acid-suppressive medications in hospitalized patients]. An Med Interna. 2002 Nov; 19(11):557-60. Zink DA, Pohlman M, Barnes M, Cannon ME. Long-term use of acid suppression started inappropriately during hospitalization. Aliment Pharmacol Ther. 2005 May 15; 21(10):1203-9. Khudair IF, Sadik ND, Hanssens YI. Prescribing pattern of acid suppressive medications for medical inpatients in a teaching hospital in Qatar. Saudi Med J. 2009 Jan; 30(1):125-9. Zeitoun A, Zeineddine M, Dimassi H. Stress ulcer prophylaxis guidelines: Are they being implemented in Lebanese health care centers? World J Gastrointest Pharmacol Ther. 2011; 2(4): 27-35 Bez C, Perrottet N, Zingg T, Leung Ki EL, Demartines N, Pannatier A. Stress ulcer prophylaxis in non-critically ill patients: a prospective evaluation of current practice in a general surgery department. J Eval Clin Pract. 2013 Apr; 19(2):374-8. Gupta R, Garg P, Kottoor R, Munoz JC, Jamal MM, Lambiase LR, et al. Overuse of Acid Suppression Therapy in Hospitalized Patients. South Med J. 2010; 103(3): 207-11. Hussain S, Stefan M, Visintainer P, Rothberg M. Why Do Physicians Prescribe Stress Ulcer Prophylaxis to General Medicine Patients? Sout Med J. 2010; 103(11): 1103-10. Issa I, Soubra O, Nakkash H, Soubra L. Variables Associated with Stress Ulcer Prophylaxis Misuse: A Retrospective Analysis. Dig Dis Sci. 2012 Oct; 57(10):2633-41. Dial S, Delaney JA, Barkun AN, Suissa S. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA. 2005 Dec 21; 294(23):2989-95. Dial S, Alrasadi K, Manoukian C, Huang A, Menzies D. Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies. CMAJ. 2004 Jul 6; 171(1):33-8. Lowe DO, Mamdani MM, Kopp A, Low DE, Juurlink DN. Proton pump inhibitors and hospitalization for Clostridium difficile-associated disease: a population-based study. Clin Infect Dis. 2006 Nov 15; 43(10):1272-6. Laheij RJ, Sturkenboom MC, Hassing RJ, Dieleman J, Stricker BH, Jansen JB. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. JAMA. 2004 Oct 27; 292(16):1955-60. Herzig SJ, Howell MD, Ngo LH, Marcantonio ER. Acid-suppressive medication use and the risk for hospital-acquired pneumonia. JAMA. 2009 May 27; 301(20):2120-8. Laine L. Protom pump inhibitors and bone fractrures?. 2009 Mar; 104 Suppl 2:S21-6. Eom CS, Park SM, Myung SK, Yun JM, Ahn JS. Use of Acid- Suppressive Drugs and Risk of Fracture: A Meta-analysis of Observational Studies. Ann Fam Med. 2011; 11(9): 257-67. Erstad BL, Camamo JM, Miller MJ, Webber AM, Fortune J. Impacting cost and appropriateness of stress ulcer prophylaxis at a university medical center. Crit Care Med. 1997 Oct; 25(10):1678-84. Wadibia EC, Lucas BD, Hilleman DE, Mooss AN. Economic impact of inappropiate histamine 2-receptor antagonist use. Clin Ther. 1997 Sep-Oct; 19(5):1085-91. Heidelbaugh JJ, Inadomi JM. Magnitude and economic impact of inappropriate use of stress ulcer prophylaxis in non-ICU hospitalized patients. Am J Gastroenterol. 2006 Oct; 101(10):2200-5. Saultz A, Judkins DZ, Saultz JW, Fashner J. What Gl stress ulcer prophylaxis should we provide hospitalized patients?. J Fam Prac. 2007; 56(1): 51-2. Kleb FH, Scholmerich J. Future expectations in the prophylaxis of intestinal bleeding. Best Pract Res Clin Gastroenterol. 2008; 22(2):373-87. Lanza F, Chan F, Quigley E. Guidelines for prevention of NSAID-Related ulcer complications. Am J Gastroenterol. 2009; 104(3): 728-38. Guillamondegui OD, Gunter OL Jr, Bonadies JA, Coates JE, Kurek SJ, De Moya MA. Practice management guidelines for stress ulcer prophylaxis [monografía en Internet]. Rockville, MD: Agency for Healthcare Research and Quality; 2008 [citado 24 Jul 2013]. Disponible en: http://guidelines.gov/content.aspx?id=12635. Dworzynski K, Pollit V, Kelsey A, Higgins B, Palmer K. Management of acute upper gastrointestinal bleeding: summary of NICE guidance. BMJ. 2012 Jun 13; 344:e3412. Yachimski PS, Farrell EA, Hunt DP, Reid AE. Proton pump inhibitors for prophylaxis of nosocomial upper gastrointestinal tract bleeding: effect of standardized guidelines on prescribing practice. Arch Intern Med. 2010 May 10; 170(9):779-83. Khalili H, Dashti-Khavidaki S, Hossein Talasaz A, Tabeefar H, Hendoiee N. Descriptive Analysis of a Clinical Pharmacy Intervention to Improve the Appropriate Use of Stress Ulcer Prophylaxis in a Hospital Infectious Disease Ward. J Manag Care Pharm. 2010; 16(2):114-21. Coursol C, Sanzari S. Impact of Stress Ulcer Prophylaxis Algorithm Study. Ann Pharmacother. 2005; 39:810-6.
dc.relation.bitstream.none.fl_str_mv	https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/736/775
dc.relation.citationedition.spa.fl_str_mv	Núm. 1 , Año 2014 : Enero – Marzo
dc.relation.citationendpage.none.fl_str_mv	17
dc.relation.citationissue.spa.fl_str_mv	1
dc.relation.citationstartpage.none.fl_str_mv	9
dc.relation.citationvolume.spa.fl_str_mv	23
dc.relation.ispartofjournal.spa.fl_str_mv	Revista Repertorio de Medicina y Cirugía
dc.rights.spa.fl_str_mv	Fundación Universitaria de Ciencias de la Salud FUCS - 0
dc.rights.accessrights.spa.fl_str_mv	info:eu-repo/semantics/openAccess
dc.rights.uri.spa.fl_str_mv	https://creativecommons.org/licenses/by-nc-sa/4.0/
dc.rights.coar.spa.fl_str_mv	http://purl.org/coar/access_right/c_abf2
rights_invalid_str_mv	Fundación Universitaria de Ciencias de la Salud FUCS - 0 https://creativecommons.org/licenses/by-nc-sa/4.0/ http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv	openAccess
dc.format.mimetype.spa.fl_str_mv	application/pdf
dc.publisher.spa.fl_str_mv	Sociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la Salud
dc.source.spa.fl_str_mv	https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/736
institution	Fundación Universitaria de Ciencias de la Salud - FUCS
bitstream.url.fl_str_mv	https://repositorio.fucsalud.edu.co/bitstreams/8a013c74-0983-493d-8610-b19da8f6f827/download
bitstream.checksum.fl_str_mv	0006346b8df1be6f62806f0ff186bd38
bitstream.checksumAlgorithm.fl_str_mv	MD5
repository.name.fl_str_mv	Repositorio Digital de la Fundación Universitaria de Ciencias de la Salud
repository.mail.fl_str_mv	redi@fucsalud.edu.co
_version_	1814355570058067968
spelling	Diaztagle F., Juan José8ec17fe7ead507031d745b7f08f66a18300Cruz B., Roberto H.3ac52489a1f5e577add70aa0495e945e300Eslava O., David F.3688bf8c0ed2f8ca5cdbaa6f95278519300Briceño P., Juan F.3134512e0fb608d172535fd81fdad5d0300Hernández A., Andrés C.c40d573a3e8b3118f7ec89c117c6f851300Jiménez M., Nataliaa7873c7705d0dc0ea9c501058c7c5faa300Jiménez M., Mónicac88b76113092c8085cc5feaa44372930300Melo F., Laura C.789eab8a597069eaa3a712aedab4fa98300Sierra M., Ronald E.5b19634ef0e404cb50e8c2a1e8b647e5300Vásquez H., Leonidas11414d9db21adf6277e6576b1a35d14d3002014-03-01 00:00:002022-06-29T19:36:12Z2014-03-012014-03-01 00:00:002022-06-29T19:36:12ZSociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la SaludFundación Universitaria de Ciencias de la Salud FUCS - 0info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/4.0/http://purl.org/coar/access_right/c_abf2https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/736úlceras de estrésprofilaxissangrado gastrointestinalterapia de supresión ácidainhibidores de bomba de protonesantagonistas de receptores de histamina tipo 2Stress ulcersprophylaxisgastrointestinal bleedingacid suppression therapyproton pump inhibitorshistamine 2 receptor antagonistsSangrado gastrointestinal en pacientes hospitalizadosGastrointestinal bleeding in hospitalized patientsapplication/pdfArtículo de revistaJournal articlehttp://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_dcae04bchttp://purl.org/coar/resource_type/c_2df8fbb1info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionTexthttp://purl.org/redcol/resource_type/ARTREVhttp://purl.org/coar/version/c_970fb48d4fbd8a8510.31260/RepertMedCir.v23.n1.2014.7360121-7372https://repositorio.fucsalud.edu.co/handle/001/27602462-991Xhttps://doi.org/10.31260/RepertMedCir.v23.n1.2014.736spaMarik P, Vasu T, Hirani A, Pachinburavan M. Stress ulcer prophylaxis in the new millenium: A systematic review and meta-analysis. Crit Care Med. 2010; 38:2222-28.Grube RR, May DB. Stress ulcer prophylaxis in hospitalized patients not in intensive care units. Am J Health Syst Pharm. 2007 Jul 1; 64(13):1396-400.Fennerty MB. Pathophysiology of the upper gastrointestinal tract in the critically ill patient: rationale for the therapeutic benefits of acid suppression. Crit Care Med. 2002 Jun; 30(6 Suppl):S351-5.Mutlu GM, Mutlu EA, Factor P. GI complications in patients receiving mechanical ventilation. Chest. 2001;119(4):1222-41.Metz DC. Preventing the gastrointestinal consequences of stress-related mucosal disease. Curr Med Res Opin. 2005 Jan; 21(1):11-8.Quenot JP, Thiery N, Barbar S. When should stress ulcer prophylaxis be used in the ICU?. Curr Opin Crit Care. 2009; 15:139-43.Amaral MC, Favas C, Alves JD, Riso N, Riscado MV. Stress-related mucosal disease: Incidence of bleeding and the role of omeprazole in its prophylaxis. Eur J Int Med. 2010; 21(5):386-88.Qadeer MA, Richter JE, Brotman DJ. Hospital-acquired gastrointestinal bleeding outside the critical care unit: risk factors, role of acid suppression, and endoscopy findings. J Hosp Med. 2006 Jan; 1(1):13-20.Herzig SJ, Vaughn BP, Howell MD, Ngo LH, Marcantonio ER. Acid-suppressive medication use and the risk for nosocomial gastrointestinal tract bleeding. Arch Intern Med. 2011 Jun 13; 171(11):991-7.Cook DJ, Fuller HD, Guyatt GH, Marshall JC, Leasa D, Hall R, et al. Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group. N Engl J Med. 1994 Feb 10; 330(6):377-81.Cook D, Heyland D, Griffith L, Cook R, Marshall J, Pagliarello J. Risk factors for clinically important upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group. Crit Care Med. 1999 Dec; 27(12):2812-7.Steinberg KP. Stress-related mucosal disease in the critically ill patient: risk factors and strategies to prevent stress-related bleeding in the intensive care unit. Crit Care Med. 2002 Jun; 30 (6 Suppl):S362-4.Stollman N, Metz DC. Pathophysiology and prophylaxis of stress ulcer in intensive care unit patients. J Crit Care. 2005 Mar; 20(1):35-45.Martindale RG. Contemporary strategies for the prevention of stress-related mucosal bleeding. Am J Health Syst Pharm. 2005 May 15; 62(10 Suppl 2):S11-7.Terdiman JP, Ostroff JW. Gastrointestinal bleeding in the hospitalized patient: a case-control study to assess risk factors, causes, and outcome. Am J Med. 1998 Apr; 104(4):349-54.Estruch R, Pedrol E, Castells A, Masanes F, Marrades RM, Urbano-Marquez A. Prophylaxis of gastrointestinal tract bleeding with magaldrate in patients admitted to a general hospital ward. Scand J Gastroenterol. 1991 Aug; 26(8):819-26.Grau JM, Casademont J, Fernandez-Sola J, Cardellach F, Urbano-Marquez A. Prophylaxis of gastrointestinal tract bleeding in patients admitted to a general hospital ward. Comparative study of sucralfate and cimetidine. Scand J Gastroenterol. 1993 Mar; 28(3):244-8.ASHP Therapeutic Guidelines on Stress Ulcer Prophylaxis. ASHP Commission on Therapeutics and approved by the ASHP Board of Directors on November 14, 1998. Am J Health Syst Pharm. 1999 Feb 15; 56(4):347-79.Cook D, Guyatt G, Marshall J, Leasa D, Fuller H, Hall R, et al. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. N Engl J Med. 1998 Mar 19; 338(12):791-7.Conrad SA, Gabrielli A, Margolis B, Quartin A, Hata JS, Frank WO, et al. Randomized, double blind comparison of immediate-release omeprazole-oral suspension versus intravenous cimetidina for prevention of upper gastrointestinal bleeding in critically ill patients. Crit Care Med. 2005; 33(4):760-65.Cook DJ, Witt LG, Cook RJ, Guyatt GH. Stress ulcer prophylaxis in the critically ill. A meta-analysis. Am J Med. 1991 Nov; 91(5):519-27.Tryba M. Prophylaxis of stress ulcer bleeding. A meta-analysis. J Clin Gastroenterol. 1991; 13 Suppl 2:S44-55.Cook DJ, Reeve BK, Guyatt GH, Heyland DK, Griffith LE, Buckingham L, et al. Stress ulcer prophylaxis in critically ill patients. Resolving discordant metaanalyses. JAMA 1996; 275 (4): 308-14.Lin P, Chang Ch, Hsu P, Tseng P, Huang Y. The efficacy and safety of protom pump inhibitors vs histamine-2 receptor antagonist for stress ulcer bleeding prophylaxis among critical care patients: A metanalysis. Crit Care Med. 2010: 38(4): 1197-1205.Pham CQ, Regal RE, Bostwick TR, Knauf KS. Acid suppressive therapy use on an inpatient internal medicine service. Ann Pharmacother. 2006 Jul-Aug; 40(7-8):1261-6.Nardino RJ, Vender RJ, Herbert PN. Overuse of acid-suppressive therapy in hospitalized patients. Am J Gastroenterol. 2000 Nov; 95(11):3118-22.Noguerado Asensio A, Rodriguez Barrientos R, Zelaya Castro P, Sanchez Sempere A, Antuna Blanco F, Lutz Garcia E, et al. [Use of acid-suppressive medications in hospitalized patients]. An Med Interna. 2002 Nov; 19(11):557-60.Zink DA, Pohlman M, Barnes M, Cannon ME. Long-term use of acid suppression started inappropriately during hospitalization. Aliment Pharmacol Ther. 2005 May 15; 21(10):1203-9.Khudair IF, Sadik ND, Hanssens YI. Prescribing pattern of acid suppressive medications for medical inpatients in a teaching hospital in Qatar. Saudi Med J. 2009 Jan; 30(1):125-9.Zeitoun A, Zeineddine M, Dimassi H. Stress ulcer prophylaxis guidelines: Are they being implemented in Lebanese health care centers? World J Gastrointest Pharmacol Ther. 2011; 2(4): 27-35Bez C, Perrottet N, Zingg T, Leung Ki EL, Demartines N, Pannatier A. Stress ulcer prophylaxis in non-critically ill patients: a prospective evaluation of current practice in a general surgery department. J Eval Clin Pract. 2013 Apr; 19(2):374-8.Gupta R, Garg P, Kottoor R, Munoz JC, Jamal MM, Lambiase LR, et al. Overuse of Acid Suppression Therapy in Hospitalized Patients. South Med J. 2010; 103(3): 207-11.Hussain S, Stefan M, Visintainer P, Rothberg M. Why Do Physicians Prescribe Stress Ulcer Prophylaxis to General Medicine Patients? Sout Med J. 2010; 103(11): 1103-10.Issa I, Soubra O, Nakkash H, Soubra L. Variables Associated with Stress Ulcer Prophylaxis Misuse: A Retrospective Analysis. Dig Dis Sci. 2012 Oct; 57(10):2633-41.Dial S, Delaney JA, Barkun AN, Suissa S. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA. 2005 Dec 21; 294(23):2989-95.Dial S, Alrasadi K, Manoukian C, Huang A, Menzies D. Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies. CMAJ. 2004 Jul 6; 171(1):33-8.Lowe DO, Mamdani MM, Kopp A, Low DE, Juurlink DN. Proton pump inhibitors and hospitalization for Clostridium difficile-associated disease: a population-based study. Clin Infect Dis. 2006 Nov 15; 43(10):1272-6.Laheij RJ, Sturkenboom MC, Hassing RJ, Dieleman J, Stricker BH, Jansen JB. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. JAMA. 2004 Oct 27; 292(16):1955-60.Herzig SJ, Howell MD, Ngo LH, Marcantonio ER. Acid-suppressive medication use and the risk for hospital-acquired pneumonia. JAMA. 2009 May 27; 301(20):2120-8.Laine L. Protom pump inhibitors and bone fractrures?. 2009 Mar; 104 Suppl 2:S21-6.Eom CS, Park SM, Myung SK, Yun JM, Ahn JS. Use of Acid- Suppressive Drugs and Risk of Fracture: A Meta-analysis of Observational Studies. Ann Fam Med. 2011; 11(9): 257-67.Erstad BL, Camamo JM, Miller MJ, Webber AM, Fortune J. Impacting cost and appropriateness of stress ulcer prophylaxis at a university medical center. Crit Care Med. 1997 Oct; 25(10):1678-84.Wadibia EC, Lucas BD, Hilleman DE, Mooss AN. Economic impact of inappropiate histamine 2-receptor antagonist use. Clin Ther. 1997 Sep-Oct; 19(5):1085-91.Heidelbaugh JJ, Inadomi JM. Magnitude and economic impact of inappropriate use of stress ulcer prophylaxis in non-ICU hospitalized patients. Am J Gastroenterol. 2006 Oct; 101(10):2200-5.Saultz A, Judkins DZ, Saultz JW, Fashner J. What Gl stress ulcer prophylaxis should we provide hospitalized patients?. J Fam Prac. 2007; 56(1): 51-2.Kleb FH, Scholmerich J. Future expectations in the prophylaxis of intestinal bleeding. Best Pract Res Clin Gastroenterol. 2008; 22(2):373-87.Lanza F, Chan F, Quigley E. Guidelines for prevention of NSAID-Related ulcer complications. Am J Gastroenterol. 2009; 104(3): 728-38.Guillamondegui OD, Gunter OL Jr, Bonadies JA, Coates JE, Kurek SJ, De Moya MA. Practice management guidelines for stress ulcer prophylaxis [monografía en Internet]. Rockville, MD: Agency for Healthcare Research and Quality; 2008 [citado 24 Jul 2013]. Disponible en: http://guidelines.gov/content.aspx?id=12635.Dworzynski K, Pollit V, Kelsey A, Higgins B, Palmer K. Management of acute upper gastrointestinal bleeding: summary of NICE guidance. BMJ. 2012 Jun 13; 344:e3412.Yachimski PS, Farrell EA, Hunt DP, Reid AE. Proton pump inhibitors for prophylaxis of nosocomial upper gastrointestinal tract bleeding: effect of standardized guidelines on prescribing practice. Arch Intern Med. 2010 May 10; 170(9):779-83.Khalili H, Dashti-Khavidaki S, Hossein Talasaz A, Tabeefar H, Hendoiee N. Descriptive Analysis of a Clinical Pharmacy Intervention to Improve the Appropriate Use of Stress Ulcer Prophylaxis in a Hospital Infectious Disease Ward. J Manag Care Pharm. 2010; 16(2):114-21.Coursol C, Sanzari S. Impact of Stress Ulcer Prophylaxis Algorithm Study. Ann Pharmacother. 2005; 39:810-6.https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/736/775Núm. 1 , Año 2014 : Enero – Marzo171923Revista Repertorio de Medicina y CirugíaPublicationOREORE.xmltext/xml3041https://repositorio.fucsalud.edu.co/bitstreams/8a013c74-0983-493d-8610-b19da8f6f827/download0006346b8df1be6f62806f0ff186bd38MD51001/2760oai:repositorio.fucsalud.edu.co:001/27602024-02-02 13:11:54.164https://creativecommons.org/licenses/by-nc-sa/4.0/Fundación Universitaria de Ciencias de la Salud FUCS - 0metadata.onlyhttps://repositorio.fucsalud.edu.coRepositorio Digital de la Fundación Universitaria de Ciencias de la Saludredi@fucsalud.edu.co

Sangrado gastrointestinal en pacientes hospitalizados

Publicaciones similares